Wheeler RH - Search Results

1

Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical aspects.

LoBuglio AF, Saleh MN, Lee J, Khazaeli MB, Carrano R, Holden H, Wheeler RH. LoBuglio AF, et al. Among authors: wheeler rh. J Natl Cancer Inst. 1988 Aug 17;80(12):932-6. doi: 10.1093/jnci/80.12.932. J Natl Cancer Inst. 1988. PMID: 3398068

2

Initial evaluation of a human immunoglobulin M monoclonal antibody (HA-1A) in humans.

Khazaeli MB, Wheeler R, Rogers K, Teng N, Ziegler E, Haynes A, Saleh MN, Hardin JM, Bolmer S, Cornett J, et al. Khazaeli MB, et al. J Biol Response Mod. 1990 Apr;9(2):178-84. J Biol Response Mod. 1990. PMID: 2341860

3

Phase I clinical trial of CO17-1A monoclonal antibody.

Lobuglio AF, Saleh M, Peterson L, Wheeler R, Carrano R, Huster W, Khazaeli MB. Lobuglio AF, et al. Hybridoma. 1986 Jul;5 Suppl 1:S117-23. Hybridoma. 1986. PMID: 3488950

4

Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer.

Saleh MN, Khazaeli MB, Wheeler RH, Bucy RP, Liu T, Everson MP, Munn DH, Schlom J, LoBuglio AF. Saleh MN, et al. Among authors: wheeler rh. Cancer Res. 1995 Oct 1;55(19):4339-46. Cancer Res. 1995. PMID: 7671245 Clinical Trial.

5

A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancer.

Saleh MN, Khazaeli MB, Grizzle WE, Wheeler RH, Lawson S, Liu T, Russel C, Meredith R, Schlom J, LoBuglio AF. Saleh MN, et al. Among authors: wheeler rh. Cancer Res. 1993 Oct 1;53(19):4555-62. Cancer Res. 1993. PMID: 8402627 Clinical Trial.

6

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer.

Robert F, Ezekiel MP, Spencer SA, Meredith RF, Bonner JA, Khazaeli MB, Saleh MN, Carey D, LoBuglio AF, Wheeler RH, Cooper MR, Waksal HW. Robert F, et al. Among authors: wheeler rh. J Clin Oncol. 2001 Jul 1;19(13):3234-43. doi: 10.1200/JCO.2001.19.13.3234. J Clin Oncol. 2001. PMID: 11432891 Clinical Trial.

7

Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancer.

Meredith RF, Khazaeli MB, Liu T, Plott G, Wheeler RH, Russell C, Colcher D, Schlom J, Shochat D, LoBuglio AF. Meredith RF, et al. Among authors: wheeler rh. J Nucl Med. 1992 Sep;33(9):1648-53. J Nucl Med. 1992. PMID: 1517839 Free article. Clinical Trial.

8

Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma.

Saleh MN, Khazaeli MB, Wheeler RH, Allen L, Tilden AB, Grizzle W, Reisfeld RA, Yu AL, Gillies SD, LoBuglio AF. Saleh MN, et al. Among authors: wheeler rh. Hum Antibodies Hybridomas. 1992 Jan;3(1):19-24. Hum Antibodies Hybridomas. 1992. PMID: 1576319 Clinical Trial.

9

Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma.

Saleh MN, Khazaeli MB, Wheeler RH, Dropcho E, Liu T, Urist M, Miller DM, Lawson S, Dixon P, Russell CH, et al. Saleh MN, et al. Among authors: wheeler rh. Cancer Res. 1992 Aug 15;52(16):4342-7. Cancer Res. 1992. PMID: 1643631 Clinical Trial.

10

Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans.

Khazaeli MB, Saleh MN, Liu TP, Meredith RF, Wheeler RH, Baker TS, King D, Secher D, Allen L, Rogers K, et al. Khazaeli MB, et al. Among authors: wheeler rh. Cancer Res. 1991 Oct 15;51(20):5461-6. Cancer Res. 1991. PMID: 1913665 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters